Noble Pillar Capital, operating under the legal name NOBLE PILLAR CAPITAL LTD, now has a Wikipedia page on the Minangkabau-language edition, summarizing publicly available information from SEC filings and other sources. The page, titled "Noble Pillar Capital," provides details on the company's regulatory filings, business activities in Japan, management team, and New York business addresses.
According to the U.S. Securities and Exchange Commission's Investment Adviser Public Disclosure system, NOBLE PILLAR CAPITAL LTD has filed reports as an Exempt Reporting Adviser (ERA) with CRD number 342309 and SEC file number 802-136385. The public filing date is April 29, 2026. ERA status means the company relies on exemptions under the Investment Advisers Act of 1940, such as those for certain private fund advisers, while remaining subject to reporting obligations like Form ADV filings. The SEC IAPD record is available at https://adviserinfo.sec.gov/firm/summary/342309.
The SEC EDGAR database contains two Form D notices filed by Noble Pillar Capital. A Form D filed on May 8, 2026, lists the company as the issuer in the "Other Banking and Financial Services" category, offering equity, pooled investment fund interests, options, and other securities. The filing reports an aggregate amount sold of USD 100 million. This should not be interpreted as registered capital or assets under management. The May 8 filing is available at https://www.sec.gov/Archives/edgar/data/2133921/000213392126000001/xslFormDX01/primary_doc.xml. A second Form D filed on June 4, 2026, identifies Kazuhiko Abe as a director and authorized signatory, and lists 432 Park Avenue, New York, NY 10022 as a principal business address. That filing is available at https://www.sec.gov/Archives/edgar/data/2133921/000213392126000003/xslFormDX08/primary_doc.xml. Form D notices are filed for exempt securities offerings and do not imply SEC approval.
According to the company's official website, its principal activities include private investment, financial services, and financial education, with interests in consumer products, healthcare, manufacturing, technology, financial services, and renewable energy. Investment updates have referenced biotechnology, radiopharmaceuticals, precision cancer treatment, automotive lidar, energy storage systems, and neurodegenerative disease treatments. In Japan, the company focuses on financial education covering long-term investing, risk management, and market cycles.
Public SEC filings reference two New York addresses: 250 Greenwich Street, 7 World Trade Center, and 432 Park Avenue. A Japan office is listed at 1-10-6 Tsukiji, Chuo-ku, Tokyo. Readers should consult the most recent filings for current address information. The Wikipedia page serves as a reference consolidating SEC data, but it is not a regulatory filing or endorsement. Investors should verify details through original SEC records.
